ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 1,056,200 | $257,839,544 | 0.92% | ||
| 2. | Greenvale Capital Bruce Emery | 700,000 | $170,884,000 | -4% | 9.75% |
| 3. | Coatue Management Philippe Laffont | 473,179 | $115,512,457 | 0.42% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 403,472 | $98,495,585 | -1% | 0.11% |
| 5. | Millennium Management Israel Englander | 389,202 | $95,011,992 | -11% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | Director | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $248.91 | 74 | Officer | 9,113 | 2024-12-02 | Filing | |
| $249.67 | 2,000 | Officer | 0 | 2024-11-27 | Filing | |
| $243.09 | 6,160 | Officer | 21,718 | 2024-11-22 | Filing | |
| $248.81 | 796 | Director | 6,723 | 2024-11-12 | Filing | |
| $246.26 | 14,683 | Officer | 464,254 | 2024-11-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,743,457 | $3,052,229,474 | 0.06% | |
| 2. | 12,248,180 | $2,106,931,925 | 0.05% | |
| 3. | 6,290,089 | $1,082,021,110 | 0.05% | |
| 4. | 3,435,280 | $589,462,559 | 0.06% | |
| 5. | 2,529,218 | $435,076,071 | 0.03% |
News See All
ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Q4 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed Second Quarter Fiscal Year 2024 Earnings Conference Call and Webcast.
ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed First Quarter Fiscal Year 2024 Earnings Conference Call and Webcast [Operator Instructions]. As a reminder, this conference is being recorded.
5 Oversold Healthcare Stocks to Buy
Root, Switzerland-based NovoCure Limited (NASDAQ:NVCR) is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization...
5 Oversold Growth Stocks To Buy
In this piece, we will take a look at the five oversold growth stocks to buy.
ResMed Inc. (NYSE:RMD) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to ResMed's Fourth Quarter Fiscal Year 2023 Earnings Conference Call and Webcast. [Operator Instructions].
Billionaire Hedge Funds
